Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome
Journal of Personalized Medicine · 28.02.2025 · 15 (3) · 94
DOI: 10.3390/jpm15030094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 28.02.2025. Verfasst von Dimitra Mougiou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clostridioides difficile (C. difficile) is a significant healthcare-associated pathogen that is predominantly caused by antibiotic-induced microbiota disturbance. Antibiotics decrease microbial diversity, resulting in C. difficile colonization and infection. Clostridium difficile infection (CDI) manifests through toxins A and B, causing diarrhea and colitis. Antibiotic usage, old age, and hospitalization are significant risk factors. A healthy gut microbiota, which is dominated by Firmicutes and Bacteroidetes, provides colonization resistance to C. difficile due to competition for nutrients, creating inhibitory substances and stimulating the immune response. Antibiotic-induced dysbiosis decreases resistance, allowing C. difficile spores to transform into vegetative forms. Patients with CDI have decreased gut microbiota diversity, with a decrease in beneficial bacteria, including Bacteroidetes, Prevotella, and Bifidobacterium, and a rise in harmful bacteria like Clostridioides and Lactobacillus. This disparity worsens the infection’s symptoms and complicates therapy. Fecal Microbiota Transplantation (FMT) has emerged as a potential therapy for recurrent CDI by restoring gut microbiota diversity and function. Comprehending the connection between gut microbiota and CDI pathogenesis is critical for establishing effective preventive and treatment plans. Maintaining a healthy gut microbiota through careful antibiotic use and therapeutic options such as FMT can help in the management and prevention of CDI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Department of Microbiology, AHEPA University Hospital, 54124 Thessaloniki, Greece.
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Cleo Anastassopoulou, Melania Kachrimanidou
Zitieren
APA
Mougiou, D., Gioula, G., Skoura, L., Anastassopoulou, C., & Kachrimanidou, M. (2025). Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome. Journal of Personalized Medicine, 15(3), 94. https://doi.org/10.3390/jpm15030094
Vancouver
Mougiou D, Gioula G, Skoura L, Anastassopoulou C, Kachrimanidou M. Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome. Journal of Personalized Medicine. 2025;15(3):94. doi:10.3390/jpm15030094
BibTeX
@article{Mougiou2025,
author = {Mougiou, Dimitra and Gioula, Georgia and Skoura, Lemonia and Anastassopoulou, Cleo and Kachrimanidou, Melania},
title = {Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {3},
pages = {94},
doi = {10.3390/jpm15030094}
}
EUVIMED